Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives

Sara La Manna1, Ilaria De Benedictis1, Daniela Marasco1

  • 1Department of Pharmacy, University of Naples "Federico II", Naples, Italy.

Insights

The JAK-STAT pathway regulates cell growth and immunity. Natural inhibitors, like Suppressors of Cytokine Signaling (SOCS) proteins, offer therapeutic potential for immune disorders and cancer by modulating this pathway.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Signaling

Background:

  • The Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathway is a critical signaling cascade involved in cell growth, differentiation, and immune responses.
  • Dysregulation of the JAK-STAT pathway is implicated in neuroinflammatory diseases and cancer immune evasion.
  • Protein-protein interactions (PPIs) are integral to the regulation of this pathway.

Purpose of the Study:

  • To review strategies for targeting the JAK-STAT pathway for therapeutic development.
  • To focus on natural inhibitors, specifically Suppressors of Cytokine Signaling (SOCS) proteins, as a therapeutic avenue.
  • To highlight the potential of targeting JAK-STAT in cancer immunotherapy and immune deficiency disorders.

Main Methods:

  • Review of existing literature on the JAK-STAT pathway and its inhibitors.
  • Analysis of the role of Suppressors of Cytokine Signaling (SOCS) proteins in immune homeostasis.
  • Exploration of therapeutic implications of targeting JAK-STAT signaling.

Main Results:

  • The JAK-STAT pathway mediates cytokine and growth factor signaling, impacting cell fate.
  • SOCS proteins act as crucial negative feedback regulators within the JAK-STAT pathway.
  • Targeting JAK-STAT offers potential for treating inflammatory conditions and enhancing anti-cancer immunity.

Conclusions:

  • The JAK-STAT pathway is a significant target for drug development due to its broad biological roles.
  • SOCS proteins represent a promising class of natural inhibitors for therapeutic intervention.
  • Careful consideration of potential side effects is necessary when developing JAK-STAT inhibitors.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
12.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K